LPL LINCOLN Date: 11% August, 2016 To, To, To, ‘The Manager, The Department of Corporate | The Secretary, Listing Department, service, Ahmedabad | Stock Exchange National Stock Exchange of | Bombay Stock Exchange | Limited, India Limited, Limited, Kamdhenu Complex, Opp. Exchange Plaza, C-1, Bandra - Kurla Complex, Bandra (F), Mumbat - 400 051. Block-G, PhirozeJeejeebhoy Tower, Dalal Street, Mumbai - 400 001. Sahjanand College, Nr. Polytechnic, Panjarapole, Ahmedabad ~ 380 015, Scrip Code - LINCOLN Scrip Code - 531633 ‘Serip Code - 32428 Dear Sir, With reference to the above mention subject, Please find attached herewith press release on un-audited financial result for the quarter ended on 30% June, 2016. Press Release being issued on the quarterly unaudited financial results for the June, 2016, Kindly acknowledge the receipt of the same. ‘Thanking you, Yours faithfully, FOR LINCOLN PHARMACEUTICALS LIMITED. yh $ Oye G / AUTHORISED SIGNATORY) Encl: As above Lincoln House", Science City Road, Sols, Ahmedabad-380 060. Gujarat, India Phone: +91-79-6777 8000 | Fax:+91-79-6777 8062 E-mail: info@lincolnpharma.com | Website : www lincolnpharma.com CIN : L24230GJ1995PLC024288, 10,12, 13, Trimul Estate, Near Khatraj Chokadi, P.O. Khatraj-382721. Ta, : Katol, Dist. 2764-66500 incolnpharma.com / lincoln_khatraj@rediffmait. com Gandhinagar, [Guj)Regd. Offoce LPL LINCOU RESULTS PRESS RELEASE PHARMACEUTICALS LY PBT up By 75.12% PAT up by 67%, Operating Revenue up by 22.47% 4** Quarter FY 2016-17 Consolidated Results. Ahmedabad, August 11, 2046: Lincoln Pharmaceuticals Ltd has announced its Unaudited Financial Results for the Quarter ended on 30 June, 2016. Q1 FY 2016-17 performance Highlights (Consolidated! * Revenue from operation up by 22.47% and reach to Rs, 92.69 Cr. ag in the Correspondence Quarter. ‘* Profit Before tax (PBT) up by 75.12% and reach to Rs. 14.56 Cr. against Rs. 8.31 Cr. in the Correspondence Quarter. ‘* Profit After tax (PAT) up by 67% and reach to Rs. 10.93 Cr, against Rs. 6.54 Cr. in the st Rs. 75.68 Cr. Correspondence Quarter. * Earnings per share (EPS) up by 67% to Rs. 6.70 as against Rs. 4.01 against Correspondence Quarter. Company increases its profitability in spite of Government strict policy on DPCO and combination produets issue in Pharma Industries, company have achieved excellent profit in the first quarter ended 30" June, 2016. The company Export Turnover has been increase 77.84% from Rs. 18.95 Cr. to Rs. 33.70 Cr. In the first quarter against correspondence quarter. About Lincoin Pharmaceuticals ite Lincoln Pharmaceutical Limited is a Public Limited Company with a large shareholder base. It has its own manufacturing facilities, covering all the major dosage forms, like Tablets, Capsules, Injectables, Syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. Manufacturing facilities at Lincoln Pharmaceuticals Limited are in accordance with WHO-GMP standards and ISO-9001 Certification. FOR LINCOLN PHARMACEUTICALS LIMITED, AUTHORISED SIGNATORY. incoln House”, Science City Road, Sola, Ahmedabad-380 060. Gujarat, India 1-79-8777 BO00 | Fax: +91-79-6777 8062 \wwnvlincolnpharma.com zinfo@lincolnpharma.com | Webs +: L24230GJ1995PLC024288 Factory : 10, 12,13, Trim Estate, Near Khatraj Chokadi,P.0. Khatraj-382721. Ta, : Kalo, Dist. Gandhinagar, (Gu) Phone £02764-665000 E-mail: khatraj@lincolnpharma.com / tincoln_khatraj@reditfmaileom